BRCA1 founder variant identified in 4% of Rwandan breast cancer cases
A PLOS Genetics study of 175 Rwandan women with breast cancer identifies a recurrent BRCA1 frameshift variant in unrelated carriers, highlighting gaps in germline data from African populations.
A study published in PLOS Genetics on 2 November 2026 reports the identification of a pathogenic founder variant in BRCA1 among Rwandan women with breast cancer. The research, led by Achille V. C. Manirakiza and colleagues including Timothy R. Rebbeck of Harvard, examined germline data from 175 Rwandan women diagnosed with breast cancer.
Seven unrelated participants — 4% of cases and 22% of all pathogenic variant carriers in the cohort — carried the same BRCA1 frameshift variant, designated c.4065_4068del. The clustering of this variant among unrelated individuals is consistent with a founder effect, whereby a mutation present in a common ancestor becomes overrepresented in a descendant population.
The authors note that germline data from African populations remain sparse compared with data from European-ancestry cohorts, a disparity that limits the characterisation of population-specific pathogenic variants in BRCA1 and BRCA2. This matters for variant interpretation: a variant catalogued as rare or of uncertain significance in predominantly European reference databases may be a well-established pathogenic variant in a population that has been less studied.
The study does not examine clinical outcomes or treatment responses, and the authors acknowledge that a cohort of 175 cases limits statistical power. The findings contribute to the broader effort to diversify germline reference datasets and to understand how founder effects shape inherited cancer risk across under-represented populations.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
BRCA1 is a gene that helps cells repair damaged DNA. Faults — called pathogenic variants — in BRCA1 can increase the lifetime risk of breast and ovarian cancer and can be passed from parent to child through families.
Researchers studying 175 women in Rwanda who had been diagnosed with breast cancer found that seven unrelated women all carried the same specific fault in BRCA1. When the same genetic change turns up repeatedly in unrelated people from the same population, it often means the fault was inherited from a common ancestor a long time ago — a pattern called a founder effect.
The study, published in the journal PLOS Genetics, highlights that most research into inherited cancer risk has focused on people of European ancestry. This means that some genetic variants important to other populations may not yet be well described in widely used databases.
This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary source Public Library of Science · 2026-11-02A common pathogenic founder variant in Rwandan breast cancer cases